author-photo

John Firth

University of Cambridge

18

Papers

1469

Citations

Citation Trend

Filter By

Papers (15) Sort By

Journal Conference Others

Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data.

2014 BMJ
Show All
- Source
- Cite
- Save
Citations (192)
What is CKD

2011 Innovait
- John Firth
Show All
- Source
- Cite
- Save
Citations (2)
Fenofibrate and diabetic retinopathy.

2008 The Lancet
- John Firth
Show All
- Source
- Cite
- Save
Citations (6)
A Randomized Controlled Trial of Late Conversion from CNI‐Based to Sirolimus‐Based Immunosuppression Following Renal Transplantation

2005 American Journal of Transplantation
Show All
- Source
- Cite
- Save
Citations (122)
Alemtuzumab (CAMPATH 1H) Induction Therapy in Cadaveric Kidney Transplantation—Efficacy and Safety at Five Years

2005 American Journal of Transplantation
Show All
- Source
- Cite
- Save
Citations (207)
Campath 1h (alemtuzumab) In Renal Transplantation: 5-year Comparative Follow Up.

2004 Transplantation
Show All
- Source
- Cite
- Save
Citations (3)
A guide to chemical and drug-induced kidney damage

2004 The Lancet
- John Firth
Show All
- Source
- Cite
- Save
Citations (0)
Campath 1H (alemtuzumab) in renal transplantation: 5-year comparative follow up.

2004 American Journal of Transplantation
Show All
- Source
- Cite
- Save
Citations (8)
2. PROPE TOLERANCE WITH INDUCTION USING CAMPATH 1H AND LOW-DOSE CYCLOSPORIN MONOTHERAPY IN 31 CADAVERIC RENAL ALLOGRAFT RECIPIENTS( 未来のための今 : 移植-次世紀への新たなるアプロ-チ)

2000
Show All
- Source
- Cite
- Save
Citations (0)
Prope tolerance with induction using Campath 1H and low-dose cyclosporin monotherapy in 31 cadaveric renal allograft recipients.

2000 Nihon Geka Gakkai zasshi
Show All
- Source
- Cite
- Save
Citations (27)